ÂÜÀòÂÒÂ×

Moran Fattal is a Principal Scientist & Scientific Coordinator at Enlivex Therapeutics (Nasdaq: ENLV) since May 2023. Prior to this role, Moran served as a Principal Scientist at Enlivex Therapeutics starting in December 2021. Moran also has experience as a Research and Development Scientist at Enlivex Therapeutics from January 2019 to June 2022. Before working at Enlivex Therapeutics, Moran worked as a Research Assistant at GluSense Medical from January 2018 to January 2019. Moran's earlier experience includes being a Research Assistant at Valin Technologies from September 2015 to January 2018, a Research Assistant at Orgenesis Inc. from October 2013 to September 2015, a masters student and researcher at Bar Ilan University from 2010 to December 2012, and the Head of the sensory laboratory - QA at Osem Israel (Nestle group) from February 2009 to October 2009. Moran also worked as a Lab Technician at Ben-Gurion University, Dr. Tekoah's Research Laboratory from October 2007 to May 2008.

Moran Fattal completed a Biomedical Data Analyst program at AEAI - Association of Engineers and Architects in Israel in 2023. They also obtained a Project Manager certification from AEAI in the same year. Prior to that, Moran earned a Master of Science degree in Life Science & Biotechnology from Bar-Ilan University in 2012. Their undergraduate education includes a Bachelor of Science in Biotechnology Engineering from Ben-Gurion University of the Negev, which was obtained between 2003 and 2008.